We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Neuromodulation System Helps Treat Fecal Incontinence

By HospiMedica International staff writers
Posted on 14 Jan 2020
Print article
Image: The StimRouter neuromodulation system (Photo courtesy of Bioness)
Image: The StimRouter neuromodulation system (Photo courtesy of Bioness)
A new neuromodulation system treats patients with fecal incontinence (FI) by targeting the tibial nerve, located near the ankle.

The Bioness (Valencia, CA, USA) StimRouter neuromodulation system is a minimally invasive device consisting of a thin, implanted lead fitted with a conductive electrode, an external pulse transmitter (EPT), and a hand-held wireless patient programmer and controller. Electrical signals are transmitted transdermally from the EPT to a disposable user patch, down the electrical lead to the implanted electrode, and from there to the area of tibial nerve. A typical session lasts 15 to 20 minute, depending on the stimulation program selected.

StimRouter is programmed at the direction of the physician, but it is controlled by the patient to address the specific, changing pain management needs. Small and unobtrusive, the patient programmer creates a wireless connection to the EPT, allowing patients to easily turn the stimulation on or off, increase and decrease stimulation intensity, and select from up to eight stored, custom stimulation programs. An LCD display allows the patients to monitor and manage their stimulation programs and level of intensity. The system can also be used treat chronic pain and overactive bladder (OAB).

“The StimRouter is changing the lives of patients who are looking for new ways to treat not just their pain but also life-impacting conditions, such as fecal incontinence and overactive bladder,” said Todd Cushman, President and CEO of Bioness. “The clinical understanding of stimulating peripheral nerves is allowing for innovative uses of the StimRouter device in Europe, as well as potentially expanding its use in the United States beyond our current chronic pain indication in the future.”

FI and urinary incontinence (UI) constitute a major health problem affecting the lives of an estimated 400 million persons worldwide. Incontinence is also more prevalent in men and women affected by various neurological illnesses, such as multiple sclerosis, spina bifida, Parkinson’s disease, and stroke. Global demographic trends suggest that the incidence of both UI and FI will rise in the coming years, with a significant health and social burden as well as an increased economic cost for both patients and health service payers.

Related Links:
Bioness

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Vital Signs Monitor
Aurus 10

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.